Human apoB contributes to increased serum total apo(a) level in LPA transgenic mice

Lipids in Health and Disease

Volumn 3, Issue , 2004, Pages 1-32

  Teivainen, Päivi A ^a,b   Eliassen, Knut A ^c   Rubin, Edward M ^d   Djurovic, Srdjan ^a,b   Berg, Kåre ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BETA ACTIN; CHOLESTEROL; CYCLOPHILIN; FAT; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; GENE; LIPID DIET; LIPID LIVER LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SYNTHESIS; MALE; MOUSE; NONHUMAN; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; ERINACEIDAE; MUS MUSCULUS; ORYCTOLAGUS CUNICULUS; PRIMATES;

EID: 2642562964     PISSN: 1476511X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-511X-3-1     Document Type: Article

References (43)

1. Berg K: A New serum type system in man - The Lp system. Acta Pathol Microbiol Scand 1963, 59: 369-382.
2. Berg K, Dahlen G, Frick MH: Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet 1974, 6: 230-235.
3. Djurovic S, Berg K: Epidemiology of Lp(a) lipoprotein: its role in atherosclerotic/thrombotic disease. Clin Genet 1997, 52: 281-292.
4. Eaton DL, Fless GM, Kohr WJ, McLean JW, Xu QT, Miller CG, Lawn RM, Scanu AM: Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci U S A 1987, 84: 3224-3228.
5. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987, 330: 132-137.
6. Lawn RM, Boonmark NW, Schwartz K, Lindahl GE, Wade DP, Byrne CD, Fong KJ, Meer K, Patthy L: The recurring evolution of lipoprotein(a). Insights from cloning of hedgehog apolipoprotein(a). J Biol Chem 1995, 270: 24004-24009.
7. Lawn R, Patthy L, Pesole G, Saccone C: Apolipoproteins(a): a puzzling evolutionary story. J Mol Evol 1997, 44: 234-236.
8. Makino K, Abe A, Maeda S, Noma A, Kawade M, Takenaka O: Lipoprotein(a) in nonhuman primates. Presence and characteristics of Lp(a) immunoreactive materials using anti-human Lp(a) serum. Atherosclerosis 1989, 78: 81-85.
9. Hixson JE, Britten ML, Manis GS, Rainwater DL: Apolipoprotein(a) (Apo(a)) glycoprotein isoforms result from size differences in Apo(a) mRNA in baboons. J Biol Chem 1989, 264: 6013-6016.
10. Laplaud PM, Beaubatie L, Rall SC, Jr., Luc G, Saboureau M: Lipoprotein[a] is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J Lipid Res 1988, 29: 1157-1170.
11. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C: Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987, 80: 458-465.
12. Liu R, Saku K, Kostner GM, Hirata K, Zhang B, Shiomi M, Arakawa K: In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits. Eur J Clin Invest 1993, 23: 561-565.
13. Frank S, Hrzenjak A, Kostner K, Sattler W, Kostner GM: Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice. Biochim Biophys Acta 1999, 1438: 99-110.
14. Fan J, Challah M, Shimoyamada H, Shiomi M, Marcovina S, Watanabe T: Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein[a]. J Lipid Res 2000, 41: 1004-1012.
15. Maartmann-Moe K, Berg K: Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin Genet 1981, 20: 352-362.
16. Armstrong VW, Harrach B, Robenek H, Helmhold M, Walli AK, Seidel D: Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res 1990, 31: 429-441.
17. Armstrong VW, Walli AK, Seidel D: Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 1985, 26: 1314-1323.
18. Frazer KA, Narla G, Zhang JL, Rubin EM: The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet 1995, 9: 424-431.
19. Acquati F, Hammer R, Ercoli B, Mooser V, Tao R, Ronicke V, Michalich A, Chiesa G, Taramelli R, Hobbs HH, Muller HJ: Transgenic mice expressing a human apolipoprotein[a] allele. J Lipid Res 1999, 40: 994-1006.
20. Huby T, Afzal V, Doucet C, Lawn RM, Gong EL, Chapman MJ, Thillet J, Rubin EM: Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5' distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice. Arterioscler Thromb Vasc Biol 2003, 23: 1633-1639.
21. Svindland A, Berg K, Eliassen K, Lawn RM, Djurovic S, Alestrom P, Noren T, Smith A: Histopathology of arterial lesions in LPA transgenic mice on cholesterol-enriched chow. Atherosclerosis 2000, 153: 349-354.
22. Linden D, Alsterholm M, Wennbo H, Oscarsson J: PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins. J Lipid Res 2001, 42: 1831-1840.
23. Linden D, Lindberg K, Oscarsson J, Claesson C, Asp L, Li L, Gustafsson M, Boren J, Olofsson SO: Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 2002, 277: 23044-23053.
24. Wade DP, Puckey LH, Knight BL, Acquati F, Mihalich A, Taramelli R: Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene. J Biol Chem 1997, 272: 30387-30399.
25. Magnaghi P, Mihalich A, Taramelli R: Several liver specific DNAse hypersensitive sites are present in the intergenic region separating human plasminogen and apoprotein(A) genes. Biochem Biophys Res Commun 1994, 205: 930-935.
26. Puckey LH, Knight BL: Interaction of oestrogen and peroxisome proliferator-activated receptors with apolipoprotein(a) gene enhancers. Biochem J 2002, 366: 157-163.
27. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM: Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci U S A 1994, 91: 2130-2134.
28. Hospattankar AV, Law SW, Lackner K, Brewer HB, Jr.: Identification of low density lipoprotein receptor binding domains of human apolipoprotein B-100: a proposed consensus LDL receptor binding sequence of apoB-100. Biochem Biophys Res Commun 1986, 139: 1078-1085.
29. Cheesman EJ, Sharp RJ, Zlot CH, Liu CY, Taylor S, Marcovina SM, Young SG, McCormick SP: An analysis of the interaction between mouse apolipoprotein B100 and apolipoprotein(a). J Biol Chem 2000, 275: 28195-28200.
30. Trieu VN, McConathy WJ: The binding of animal low-density lipoproteins to human apolipoprotein(a). Biochem J 1995, 309 (Pt 3): 899-904.
31. Corsini A, Mazzotti M, Villa A, Maggi FM, Bernini F, Romano L, Romano C, Fumagalli R, Catapano AL: Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Atherosclerosis 1992, 93: 95-103.
32. Hofmann SL, Eaton DL, Brown MS, McConathy WJ, Goldstein JL, Hammer RE: Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest 1990, 85: 1542-1547.
33. Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, Hammer RE, Hobbs HH: Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A 1998, 95: 4544-4549.
34. Trieu VN, McConathy WJ: Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry 1990, 29: 5919-5924.
35. Ye SQ, Trieu VN, Stiers DL, McConathy WJ: Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). J Biol Chem 1988, 263: 6337-6343.
36. Fan J, Araki M, Wu L, Challah M, Shimoyamada H, Lawn RM, Kakuta H, Shikama H, Watanabe T: Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a). Biochem Biophys Res Commun 1999, 255: 639-644.
37. Puckey L, Knight B: Dietary and genetic interactions in the regulation of plasma lipoprotein(a). Curr Opin Lipidol 1999, 10: 35-40.
38. Chen JY, Levy-Wilson B, Goodart S, Cooper AD: Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J Biol Chem 2002, 277: 42588-42595.
39. Chiang JY, Kimmel R, Stroup D: Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001, 262: 257-265.
40. Pineda T, I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B: Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol 2003, 17: 259-272.
41. Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH: Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002, 110: 671-680.
42. Liu J, Zhang YL, Spence MJ, Vestal RE, Wallace PM, Grass DS: Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M. Arterioscler Thromb Vasc Biol 1997, 17: 2948-2954.
43. Berg K, Svindland A, Smith AJ, Lawn RM, Djurovic S, Alestrom A, Alestrom P, Eliassen K: Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet. Atherosclerosis 2002, 163: 99-104.